Topiramate is an insulin-sensitizing compound in vivo with direct effects on adipocytes in female ZDF rats
The DOI matches its Crossref record.
Abstract
We have studied the in vivo and in vitro effects of Topiramate (TPM) in female Zucker diabetic fatty (ZDF) rats. After weight matching, drug treatment had a marked effect to lower fasting glucose levels of relatively normoglycemic animals as well as during an oral glucose tolerance test. The glucose clamp studies revealed a ∼30% increased glucose disposal, increased hepatic glucose output (HGO) suppression from ∼30 to 60%, and an increased free fatty acid suppression from 40 to 75%. Therefore, TPM treatment led to enhanced insulin sensitivity at the level of tissue glucose disposal (increased ISGDR), liver (increased inhibition of HGO), and adipose tissue (enhanced suppression of lipolysis). When soleus muscle strips of control or TPM-treated ZDF rats were studied ex vivo, insulin-stimulated glucose transport was not enhanced in the drug-treated animals. In contrast, when isolated adipocytes were studied ex vivo, a marked increase (+55%) in insulin-stimulated glucose transport was observed. In vitro treatment of muscle strips and rat adipocytes showed no effect on glucose transport in muscle with a 40% increase in insulin-stimulated adipocyte glucose transport. In conclusion, 1) TPM treatment leads to a decrease in plasma glucose and increased in vivo insulin sensitivity; 2) insulin sensitization was observed in adipocytes, but not muscle, when tissues were studied ex vivo or in vitro; and 3) TPM directly enhances insulin action in insulin-resistant adipose cells in vitro. Thus the in vivo effects of TPM treatment appear to be exerted through adipose tissue.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
August, G. P., Caprio, S., Fennoy, I., Freemark, M., Kaufman, F. R., Lustig, R. H., Silverstein, J. H., Speiser, P. W., Styne, D. M., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2458 · Cited by 524
The metabolic face of migraine — from pathophysiology to treatment
Gross, E. C., Lisicki, M., Fischer, D., Sándor, P. S., & Schoenen, J. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0255-4 · Cited by 262
Bays, H. (2010) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.10.125 · Cited by 66
Eliasson, B., Gudbjörnsdottir, S., Cederholm, J., Liang, Y., Vercruysse, F., & Smith, U. (2007) · International Journal of Obesity · doi:10.1038/sj.ijo.0803548 · Cited by 57
Treatment of Sleep-Related Eating Disorder
Chiaro, G., Caletti, M. T., & Provini, F. (2015) · Current Treatment Options in Neurology · doi:10.1007/s11940-015-0361-6 · Cited by 46
Metadata
- Authors
- Wilkes, J. J., Nelson, E., Osborne, M., Demarest, K. T., & Olefsky, J. M.
- Venue
- American Journal of Physiology-Endocrinology and Metabolism
- Publisher
- American Physiological Society
- Published
- 2005-03
- Volume
- 288
- Issue
- 3
- Pages
- E617-E624
- ISSN
- 0193-1849 (ISSN-L)
- 1522-1555
- OpenAlex
- W1988781925
- Cited by
- 63
- References
- 0
- FWCI
- 1.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Topiramate is an insulin-sensitizing compound in vivo with direct effects on adipocytes in female ZDF rats. https://app.cochat.ai/papers/10.1152/ajpendo.00437.2004
- The paper
- Wilkes, J. J., Nelson, E., Osborne, M., Demarest, K. T., & Olefsky, J. M. (2005). Topiramate is an insulin-sensitizing compound in vivo with direct effects on adipocytes in female ZDF rats. American Journal of Physiology-Endocrinology and Metabolism. https://doi.org/10.1152/ajpendo.00437.2004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.